Your browser doesn't support javascript.
loading
Development of a selective, sensitive and robust oxyntomodulin dual monoclonal antibody immunoassay.
Umberger, Tara S; Ming, Wenyu; Cox, Jennifer M; Konrad, Robert J; Siegel, Robert W.
Afiliação
  • Umberger TS; Lilly Research Laboratories, Eli Lilly & Company, Indianapolis, IN 46285, USA.
  • Ming W; Lilly Research Laboratories, Eli Lilly & Company, Indianapolis, IN 46285, USA.
  • Cox JM; Lilly Research Laboratories, Eli Lilly & Company, Indianapolis, IN 46285, USA.
  • Konrad RJ; Lilly Research Laboratories, Eli Lilly & Company, Indianapolis, IN 46285, USA.
  • Siegel RW; Lilly Research Laboratories, Eli Lilly & Company, Indianapolis, IN 46285, USA.
Bioanalysis ; 14(18): 1229-1239, 2022 Sep.
Article em En | MEDLINE | ID: mdl-36378599
ABSTRACT
Background &

Aim:

Oxyntomodulin (Oxm) is a proglucagon-derived peptide agonist of both the GLP-1 and glucagon receptors and is a key regulator of gastric acid secretion and energy expenditure. Differential processing from proglucagon hinders assay immunoassay selectivity. Method &

results:

Antibody engineering was used to develop a sandwich immunoassay that selectively measures endogenous Oxm. The pre- and postprandial levels of Oxm from 19 healthy individuals over the course of 2 h were measured. Postprandial increases in Oxm occurred within minutes and levels significantly correlated with those obtained using previously published mass spectrometry assays.

Conclusion:

This sandwich immunoassay is appropriately sensitive and selective and is also amenable to high-throughput application for the reliable determination of endogenous levels of intact Oxm from human samples.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oxintomodulina / Anticorpos Monoclonais Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oxintomodulina / Anticorpos Monoclonais Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article